Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: Relation to coronary artery disease extension

A Palazzuoli; R Ascione; M Gallota; A Calabro; S Gonnelli; I Quatrini; MS Campagna; B Franci; R Nuti

doi:10.1016/j.ijcard.2008.05.048

Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: Relation to coronary artery disease extension

A Palazzuoli, R Ascione, M Gallota, A Calabro, S Gonnelli, I Quatrini, MS Campagna, B Franci, R Nuti

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal)

3 Citations (Scopus)

Abstract

OBJECTIVES: To analyze Osteoprotegerin (OPG), and BNP plasma levels in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), in relation to clinical presentation and to coronary atherosclerosis diffusion. METHODS: 155 CAD patients were classified in four groups: stable angina (SA n=42), unstable angina (UA n=35) non-ST elevation myocardial infarction (NSTEMI n=45) and control group (n=33), measuring OPG and BNP at hospital admission. We compared both biomarkers in relation to the number of coronary narrowed vessels (1-,2-,3 or more vessels disease), and to the stenoses degree by Duke Jeopardy score. RESULTS: OPG levels were higher in patients with CAD respect to controls (p

Original language	English
Pages (from-to)	295-298
Journal	International Journal of Cardiology
Volume	137
Issue number	3
DOIs	https://doi.org/10.1016/j.ijcard.2008.05.048
Publication status	Published - 2009

Access to Document

10.1016/j.ijcard.2008.05.048

http://www.sciencedirect.com/science/article/pii/S0167527308007638

Fingerprint Dive into the research topics of 'Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: Relation to coronary artery disease extension'. Together they form a unique fingerprint.

Cite this

Palazzuoli, A., Ascione, R., Gallota, M., Calabro, A., Gonnelli, S., Quatrini, I., Campagna, MS., Franci, B., & Nuti, R. (2009). Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: Relation to coronary artery disease extension. International Journal of Cardiology, 137(3), 295-298. https://doi.org/10.1016/j.ijcard.2008.05.048

@article{4447d686452b4f57bc0a924dd7c9f102,

title = "Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: Relation to coronary artery disease extension",

abstract = "OBJECTIVES: To analyze Osteoprotegerin (OPG), and BNP plasma levels in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), in relation to clinical presentation and to coronary atherosclerosis diffusion. METHODS: 155 CAD patients were classified in four groups: stable angina (SA n=42), unstable angina (UA n=35) non-ST elevation myocardial infarction (NSTEMI n=45) and control group (n=33), measuring OPG and BNP at hospital admission. We compared both biomarkers in relation to the number of coronary narrowed vessels (1-,2-,3 or more vessels disease), and to the stenoses degree by Duke Jeopardy score. RESULTS: OPG levels were higher in patients with CAD respect to controls (p",

author = "A Palazzuoli and R Ascione and M Gallota and A Calabro and S Gonnelli and I Quatrini and MS Campagna and B Franci and R Nuti",

year = "2009",

doi = "10.1016/j.ijcard.2008.05.048",

language = "English",

volume = "137",

pages = "295--298",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier",

number = "3",

}

Palazzuoli, A, Ascione, R, Gallota, M, Calabro, A, Gonnelli, S, Quatrini, I, Campagna, MS, Franci, B & Nuti, R 2009, 'Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: Relation to coronary artery disease extension', International Journal of Cardiology, vol. 137, no. 3, pp. 295-298. https://doi.org/10.1016/j.ijcard.2008.05.048

Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: Relation to coronary artery disease extension. / Palazzuoli, A; Ascione, R; Gallota, M; Calabro, A; Gonnelli, S; Quatrini, I; Campagna, MS; Franci, B; Nuti, R.

In: International Journal of Cardiology, Vol. 137, No. 3, 2009, p. 295-298.

Research output: Contribution to journal › Article (Academic Journal)

TY - JOUR

T1 - Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: Relation to coronary artery disease extension

AU - Palazzuoli, A

AU - Ascione, R

AU - Gallota, M

AU - Calabro, A

AU - Gonnelli, S

AU - Quatrini, I

AU - Campagna, MS

AU - Franci, B

AU - Nuti, R

PY - 2009

Y1 - 2009

N2 - OBJECTIVES: To analyze Osteoprotegerin (OPG), and BNP plasma levels in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), in relation to clinical presentation and to coronary atherosclerosis diffusion. METHODS: 155 CAD patients were classified in four groups: stable angina (SA n=42), unstable angina (UA n=35) non-ST elevation myocardial infarction (NSTEMI n=45) and control group (n=33), measuring OPG and BNP at hospital admission. We compared both biomarkers in relation to the number of coronary narrowed vessels (1-,2-,3 or more vessels disease), and to the stenoses degree by Duke Jeopardy score. RESULTS: OPG levels were higher in patients with CAD respect to controls (p

AB - OBJECTIVES: To analyze Osteoprotegerin (OPG), and BNP plasma levels in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), in relation to clinical presentation and to coronary atherosclerosis diffusion. METHODS: 155 CAD patients were classified in four groups: stable angina (SA n=42), unstable angina (UA n=35) non-ST elevation myocardial infarction (NSTEMI n=45) and control group (n=33), measuring OPG and BNP at hospital admission. We compared both biomarkers in relation to the number of coronary narrowed vessels (1-,2-,3 or more vessels disease), and to the stenoses degree by Duke Jeopardy score. RESULTS: OPG levels were higher in patients with CAD respect to controls (p

U2 - 10.1016/j.ijcard.2008.05.048

DO - 10.1016/j.ijcard.2008.05.048

M3 - Article (Academic Journal)

C2 - 18707771

VL - 137

SP - 295

EP - 298

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -